AR and posterior cortical atrophy: Targeting both of these enzymes, as well as an additional SWI/SNF protein, PBRM1, using the AU-15330 PROTAC in PCa, was demonstrated to have preferential effectiveness in enhancer-addicted AR-dependent PCa [247].